This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Ga 68 DOTATOC Market

Market Insights on Ga 68 DOTATOC covering sales outlook, demand forecast & up-to-date key trends

Ga 68 DOTATOC Market: Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

Ga 68 DOTATOC Market Overview

Ga 68 dotatoc is a radiopharmaceutical drug used with a positron emission tomography-computed tomography for the detection of somatostanin receptor positive neuroendocrine tumors.

Neuroendocrine tumors are rare kind of tumors that develop in certain cells that produce hormone of the neuroendocrine system. Ga 68 dotatoc is administered intravenously into the body to detect the site of the tumors and is also useful in evaluating the presence and extent of tumors which is required in decision making for the treatment of neuroendocrine tumors patient.

The Ga 68 dotatoc market is likely to grow over the forecast period due to the increasing prevalence of neuroendocrine tumors, and increasing awareness and adoption of radioisotopes across the globe.

The outbreak of novel coronavirus is believed to have a severe impact on the global ga 68 dotatoc market. During the COVID-19 outbreak, there has been a decrease in flow of patients into the hospitals and clinics which has led to reduced diagnostic procedures which in turn is affecting the global ga 68 dotatoc market. After the supply and production disruptions, the manufacturing industries are now facing a demand shock with an uncertain recovery timeline due to the global restrictions.

Ga 68 DOTATOC Market: Drivers and Restraints

The increasing prevalence of gastrointestinal and lung neuroendocrine tumor is the major driving factor of ga 68 dotatoc market. Furthermore, growing investment in clinical trials by leading pharmaceutical companies in order to develop novel products and increasing research and development activities for neuroendocrine tumor treatment are other drivers of ga 68 dotatoc market.

Moreover, increasing acceptance of diagnostic imaging techniques such as endoscopic ultrasonography among users is expected to boost the ga 68 dotatoc market. The increasing incidence of hormonal imbalance at thyroid gland and pituitary gland are also expected to fuel the growth of ga 68 dotatoc market.

However, due to the short half life of radiopharmaceuticals, high costs of diagnostic equipments and lack of experts to carry out the procedures limit the growth of ga 68 dotatoc market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Ga 68 DOTATOC Market: Overview

Based on the indication, the gastrointestinal neuroendocrine tumor segment is expected to hold a major share in the ga 68 dotatoc market due to the increasing prevalence of gastrointestinal disorders across the globe followed by pancreatic neuroendocrine tumors segment.

Based on the distribution channel, hospital pharmacies are expected to be the most profitable segment in the global ga 68 dotatoc market due to the availability of advanced diagnostic and treatment facilities of tumors.

Ga 68 DOTATOC Market: Region-wise Outlook

The global ga 68 dotatoc market is expected to be dominated by North America and Europe due to the increasing technological advancements in therapies, approval of new drugs and increasing adoption of radioisotopes in diagnosis of the tumors in the region.

Furthermore, rising strategic collaboration, acquisition and merger by players operating in the market is likely to drive the growth of the ga 68 dotatoc market in the region. Asia-Pacific is expected to have a rapid growth rate in the global ga 68dotatoc market over the forecast period, due to the increasing cases of gastrointestinal neuroendrocrine tumors, suitable regulatory environment for drugs and increasing population in the countries like India and China.

Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Ga 68 DOTATOC Market: Key Market Participants

Some of the market participants in the global ga 68 dotatoc market identified across the value chain include:

  • Novartis International AG 
  • Pfizer Inc.
  • Roche Holding AG
  • Eli Lilly & Company 
  • Bristol Myers Squibb Company 
  • Amgen Inc. 
  • Mayroy SA
  • Biosynthema 
  • Teva Pharmaceutical Industries Ltd.
  • Synergy Pharmaceuticals
  • Seimens AG 

The report covers exhaust analysis on

  • Ga 68 DOTATOC Market Segments
  • Ga 68 DOTATOC Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Ga 68 DOTATOC Market: Segmentation


  • Gastrointestinal  neuroendocrine tumor
  • Pancreatic neuroendocrine tumor
  • Lung neuroendocrine tumor
  • Others


  • Hospitals
  • Oncology Centres
  • Others

Table of Content


Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables


Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate